These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 456013)

  • 1. Disopyramide in pregnancy: a case report.
    Shaxted EJ; Milton PJ
    Curr Med Res Opin; 1979; 6(1):70-2. PubMed ID: 456013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.
    Luoma PV; Kujala PA; Juustila HJ; Takkunen JT
    J Clin Pharmacol; 1978; 18(5-6):293-301. PubMed ID: 641217
    [No Abstract]   [Full Text] [Related]  

  • 3. Initiation of uterine contractions by disopyramide during pregnancy.
    Leonard RF; Braun TE; Levy AM
    N Engl J Med; 1978 Jul; 299(2):84-5. PubMed ID: 661865
    [No Abstract]   [Full Text] [Related]  

  • 4. [Data on disopyridamide therapy of some arrhythmias].
    Perroni GB; Briguglio FS; Oddo A; Trovato G
    Minerva Med; 1977 Jun; 68(32):2271-4. PubMed ID: 69277
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
    Camm J; Ward D; Spurrell RA
    Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
    Romero-Ayala LC; SonĂ­ J
    Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways.
    Sethi KK; Jaishankar S; Khalilullah M; Gupta MP
    Br Heart J; 1983 Jun; 49(6):532-43. PubMed ID: 6849716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
    Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
    Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of disopyramide phosphate in repetitive paroxysmal ventricular tachycardia].
    Katoh T; Sasaki Y; Tsuda T
    Kokyu To Junkan; 1982 Sep; 30(9):959-64. PubMed ID: 7178700
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
    Dzieglielewski T; Wachowiak A
    Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous disopyramide phosphate and ventricular overdrive pacing in the termination of paroxysmal ventricular tachycardia.
    Camm J; Ward D; Washington HG; Spurrell RA
    Pacing Clin Electrophysiol; 1979 Jul; 2(4):395-402. PubMed ID: 95308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravenous disopyramide in acute cardiac arrhythmias.
    De Backer M; Stoupel E; Kahn RJ
    Eur J Clin Pharmacol; 1981 Jan; 19(1):11-8. PubMed ID: 6161824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disopyramide-induced ventricular fibrillation.
    Nicholson WJ; Martin CE; Gracey JG; Knoch HR
    Am J Cardiol; 1979 May; 43(5):1053-5. PubMed ID: 433766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophysiological action of disopyramide].
    Grosu AA; Malakhov VI; Smetnev AS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical studies of Norpace (Part VIII).
    Laidlaw JC
    Angiology; 1975 Jan; 26(1 Pt 2):144-5. PubMed ID: 1090215
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiarrhythmic actions of disopyramide phosphate in patients with paroxysmal supraventricular tachycardia (author's transl)].
    Satoh M; Sada T; Kuan-Min S; Kira Y; Sekine I; Okabe F; Ueda A; Ito T; Matsumoto S
    Kokyu To Junkan; 1981 May; 29(5):537-44. PubMed ID: 7313358
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of antiarrhythmic effects of disopyramide by multiclinical controlled double-blind methods.
    Kimura E; Mashima S; Tanaka T
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(8):338-43. PubMed ID: 7409935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term therapy with disopyramide phosphate: side effects and effectiveness.
    Bauman JL; Gallastegui J; Strasberg B; Swiryn S; Hoff J; Welch WJ; Bauernfeind RA
    Am Heart J; 1986 Apr; 111(4):654-60. PubMed ID: 3082173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention and therapy of supraventricular paroxysmal tachycardia in ambulatory patients. Results of a multicentric study using disopyramide].
    Rouhi A; Penth B; Adams HJ
    Ther Ggw; 1979 Jun; 118(6):957-69. PubMed ID: 462395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.